Clinical Trial Update: Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions [NA]

View source ↗

Summary

A completed clinical trial comparing the safety and efficacy of Genoss DCB versus SeQuent Please NEO in Korean patients with coronary de novo lesions (coronary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Genoss DCB (paclitaxel-coated balloon)
• SeQuent Please NEO (paclitaxel-coated balloon)

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED